Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-20-017868
Filing Date
2020-10-15
Accepted
2020-10-15 17:13:47
Documents
2
Period of Report
2020-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 6800
2 nuechterleinpoa.htm EX-24 7510
  Complete submission text file 0001567619-20-017868.txt   15710
Mailing Address C/O AVEXIS, INC., 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address
Nuechterlein Carole (Reporting) CIK: 0001665133 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39617 | Film No.: 201242091

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Issuer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)